He said: It is well established that better mental health tends to follow from better physical health and since the 1880s we have known that diabetes is associated with depression, although I think its unlikely that using GLP-1R agonists alone as treatments for depression or anxiety will work. Prof Eduard Vieta, a professor of psychiatry at the University of Barcelona and editor in chief of the European College of Neuropsychopharmacology journal, said: From a clinical perspective, these findings are reassuring regarding the psychiatric safety of GLP-1 receptor agonists and suggest a potential role not only in preventing worsening but also, possibly, in improving mental health outcomes
The path from interesting preclinical research to FDA approval is long, expensive, and requires showing safety and efficacy in human trials
This regimen promotes positive changes in gut microbiota composition, which improves metabolic health, cardiovascular function, and may lower TMAO levels
It is one of the most abundant intracellular peptides in mammals and plays a central role in cell migration, angiogenesis, and tissue protection
However, it is essential to seek guidance from a healthcare professional to determine the appropriate dosage and treatment regimen based on individual needs and medical history.
